Papers of the Week

In the United States, approximately 100,000 individuals of predominantly African ancestry have sickle cell disease (SCD). Patients with SCD present recurrent episodes of acute pain, the hallmark of the disease, and some also develop chronic pain. Currently, the treatment of SCD acute pain only targets its symptoms, rather than underlying mechanisms, and is directed by expert and consensus guidelines.